prod:prod_dcx-login
SARS-CoV-2 Portfolio
US-EUA
Xpert® Xpress CoV-2 plus*
Designed with 3 gene targets for a rapid, robust detection of SARS-CoV-2
Xpert® Xpress CoV-2/Flu/RSV plus*
Actionable rapid respiratory results to meet the challenges of co-circulating respiratory viruses